ALL$216.60

Allstate’s revenue mix is driven primarily by net premiums earned, with investment income providing a meaningful but smaller secondary stream; that mix has remained broadly stable, while TTM revenue is still growing versus FY2024. Profitability has improved sharply, with operating margin expanding from near-breakeven in FY2023 to 17.7% in FY2025 and 21.0% TTM, indicating better underwriting and earnings leverage. There is no credit-loss issue to assess, but claims costs and policy amortization remain the key expense lines, and their recent moderation has supported results. One-off items matter: FY2021 included a large discontinued-operations loss, and other non-operating income in FY2025 boosted pretax earnings. Overall, cost control and earnings durability look solid, though claims volatility remains a risk.

The balance sheet appears solid and steadily improving. Total assets rose from $99.4bn in FY2021 to $124.0bn TTM, driven mainly by a larger investment portfolio, while total liabilities increased more moderately from $74.3bn to $92.4bn. Shareholders’ equity expanded meaningfully from $25.1bn to $31.6bn, with retained earnings climbing to $64.5bn and tangible book value per share reaching $107.34 TTM. Cash is modest at under $0.7bn, but this is supported by $85.2bn of investments and a large reserve base. Total debt remains manageable at about $7.5bn. Claims reserves and unearned premiums are large, as expected, but there is no clear sign of balance sheet stress or capital erosion.

Cash generation is generally stable and improved strongly in the latest period, with operating cash flow rising to $8,931 million in FY2024 from $4,228 million in FY2023 and $8,826 million TTM. Free cash flow also strengthened to $8,721 million, comfortably above capital spending of only $210 million, suggesting limited reinvestment needs. The main volatility comes from working-capital and reserve-related items, especially claims reserves, unearned premiums, and receivables, which can swing operating cash flow materially. Capital returns have been consistent through dividends, while buybacks have moderated sharply from earlier years, with only $2 million repurchased in FY2024. Overall, cash generation and distributions look solid, though investing flows remain large and inherently variable.

The Allstate Corporation is an insurance company, so traditional liquidity ratios are not especially meaningful here. The stronger signal is profitability: ROE improved sharply from negative and low-single-digit levels in 2021–2023 to 23.6% in 2024 and about 39% in 2025/current, while ROA also rose from near breakeven to 8%–9% and ROCE climbed into double digits. That points to a much stronger earnings profile and efficient capital use. The equity base also expanded materially, suggesting improving capital resilience. Leverage appears structurally normal for an insurer and does not show obvious instability in this data. Asset turnover improved modestly, but the main takeaway is that returns strengthened meaningfully and have remained high in the latest periods.

Historical data runs through FY2025, while FY2026-FY2027 are analyst-covered forecast years. Revenue expanded from FY2021 to FY2025, with especially strong gains in FY2024-FY2025, then is expected to contract in FY2026 before a modest FY2027 recovery. EPS has been far more volatile: it turned negative in FY2022-FY2023, rebounded sharply in FY2024-FY2025, and then is projected to ease in the forecast period. That suggests earnings growth has recently outpaced revenue, implying margin improvement, but not a steady pattern. Forward P/E of 7.26x to 8.26x looks restrained rather than demanding. Sentiment is constructive overall: consensus is Buy, coverage is solid at 25 analysts, and the recommendation mix is mostly stable, though May shows a small shift from Buy to Hold.